We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Safety of Import Drugs Is Focus of Next PDUFA Reauthorization
Safety of Import Drugs Is Focus of Next PDUFA Reauthorization
May 3, 2010
The FDA plans to use funding from the next reauthorization of the Prescription Drug User Fee Act (PDUFA) to address recent challenges in regulating drug
safety, especially monitoring products manufactured abroad.